China Universal Asset Management »

Beam Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $441k 18k 24.80
2024-09-30 $394k 16k 24.50
2024-06-30 $232k 9.9k 23.43
2024-03-31 $526k 16k 33.04
2023-12-31 $263k 9.7k 27.22
2023-09-30 $55k 2.3k 24.05
2023-06-30 $39k 1.2k 31.93
2023-03-31 $37k 1.2k 30.62
2022-12-31 $37k 952 39.11
2022-09-30 $43k 895 48.04

More positions owned by China Universal Asset Management

Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Alphabet Inc-cl A Common Stock (GOOGL)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Tesla Common Stock (TSLA)
Regeneron Pharmaceuticals Common Stock (REGN)
Netflix Common Stock (NFLX)
Taiwan Semiconductor-sp Adr (TSM)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Beam Therapeutics

Farallon Capital Management
BlackRock
Vanguard Group
ARK Investment Management
Arch Venture Corp
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
FMR
State Street Corporation
MWG Management
Citadel Advisors
UBS Group
Temasek Holdings
Geode Capital Management
T. Rowe Price Associates

View all funds holding Beam Therapeutics